97 related articles for article (PubMed ID: 15052437)
21. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index.
Taylor PR; Mason RC; Filipe MI; Vaja S; Hanley DC; Murphy GM; Dowling RH; McColl I
Gut; 1991 Dec; 32(12):1447-54. PubMed ID: 1773947
[TBL] [Abstract][Full Text] [Related]
22. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
23. Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus.
Manifold DK; Marshall RE; Anggiansah A; Owen WJ
Scand J Gastroenterol; 2000 Aug; 35(8):796-801. PubMed ID: 10994616
[TBL] [Abstract][Full Text] [Related]
24. [Influence of post-vagotomy duodenogastric reflux on gastric mucosal structure].
Kaminishi M
Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):686-96. PubMed ID: 4033624
[TBL] [Abstract][Full Text] [Related]
25. Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
Rodrigues PA; Naresse LE; Rodrigues MA; Kobayasi S
Acta Cir Bras; 2013 Jun; 28(6):453-7. PubMed ID: 23743684
[TBL] [Abstract][Full Text] [Related]
26. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade.
Wetscher GJ; Hinder RA; Kretchmar D; Stinson R; Perdikis G; Smyrk T; Klingler PJ; Adrian TE
Dig Dis Sci; 1996 Nov; 41(11):2166-73. PubMed ID: 8943968
[TBL] [Abstract][Full Text] [Related]
27. Gastric proliferative lesions induced by duodenogastric reflux in rats.
Monteiro RL; Andreollo NA; Rodrigues MA; Araujo MR
Acta Cir Bras; 2006; 21(4):207-13. PubMed ID: 16862339
[TBL] [Abstract][Full Text] [Related]
28. Experimental carcinoma of the stomach in rats with chronic ulcers and following gastric surgery.
Sherenesheva NI; Patjutko JI; Klimenkov AA; Turusov VS
Arch Geschwulstforsch; 1987; 57(2):91-8. PubMed ID: 3592926
[TBL] [Abstract][Full Text] [Related]
29. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
[TBL] [Abstract][Full Text] [Related]
31. Duodenogastric reflux and gastric stump carcinoma.
Kondo K
Gastric Cancer; 2002; 5(1):16-22. PubMed ID: 12021855
[TBL] [Abstract][Full Text] [Related]
32. Gastric carcinogenesis by duodenal reflux through gut regenerative cell lineage.
Mukaisho K; Miwa K; Kumagai H; Bamba M; Sugihara H; Hattori T
Dig Dis Sci; 2003 Nov; 48(11):2153-8. PubMed ID: 14705821
[TBL] [Abstract][Full Text] [Related]
33. Effect of cimetidine on development of gastric cancer in rats after gastrojejunostomy.
Hortemo GS; Maartmann-Moe H; Rökke O; Viste A
Eur J Surg; 1999 Mar; 165(3):259-61. PubMed ID: 10231661
[TBL] [Abstract][Full Text] [Related]
34. Duodenogastric reflux and gastric mucosal polyamines in the non-operated stomach and in the gastric remnant after Billroth II gastric resection. A role in gastric carcinogenesis?
Lorusso D; Linsalata M; Pezzolla F; Berloco P; Osella AR; Guerra V; Di Leo A; Demma I
Anticancer Res; 2000; 20(3B):2197-201. PubMed ID: 10928177
[TBL] [Abstract][Full Text] [Related]
35. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
36. Duodenal reflux leads to down regulation of DNA mismatch repair pathway in an animal model of esophageal cancer.
Bonde P; Gao D; Chen L; Miyashita T; Montgomery E; Harmon JW; Wei C
Ann Thorac Surg; 2007 Feb; 83(2):433-40; discussion 440. PubMed ID: 17257966
[TBL] [Abstract][Full Text] [Related]
37. Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
Tsuji S; Sun WH; Tsujii M; Kawai N; Kimura A; Kakiuchi Y; Yasumaru S; Komori M; Murata H; Sasaki Y; Kawano S; Hori M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1301-8. PubMed ID: 12438555
[TBL] [Abstract][Full Text] [Related]
38. Does troncular vagotomy modify the proliferative gastric lesions induced in rats by duodenogastric reflux?
Rodrigues PA; Kobayasi S; Rodrigues MA
Acta Cir Bras; 2007; 22(3):210-4. PubMed ID: 17546294
[TBL] [Abstract][Full Text] [Related]
39. [Reflux of duodenal or gastroduodenal contents induces esophageal carcinoma in rats].
Miwa K; Miyashita T; Hattori T
Nihon Rinsho; 2004 Aug; 62(8):1433-8. PubMed ID: 15344531
[TBL] [Abstract][Full Text] [Related]
40. Lansoprazole and ethanol metabolism: comparison with omeprazole and cimetidine.
Battiston L; Tulissi P; Moretti M; Pozzato G
Pharmacol Toxicol; 1997 Dec; 81(6):247-52. PubMed ID: 9444664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
